Recurrent Respiratory Papillomatosis 2026: Newest Therapeutic Approaches and Opportunity for Cure

Monday, October 19, 2026

11:00 AM - 12:00 PM PT

Location: 502B

Lead Presenter(s)

Seth M. Pransky, MD

President
Pediatric Specialty Partners
La Jolla, California, United States

Co-Presenter(s)

PC

Paolo Campisi, MD

Pediatric Otolaryngologist
Hospital for Sick Children, University of Toronto
Toronto, Ontario, Canada

The updates from this session on advancements in medical and surgical treatment for RRP are critical to successful care of these patients. Attendees will learn the critical role of and timing for "adjuvant therapy", the impact of preventative vaccination, the changing demographics for this disease, surgical advances and the considerable research leading to IV bevacizumab and the newer therapeutic DNA immunotherapy for those patients with more extensive disease.The course will focus on practical management strategies and "pearls" to improve airway and voice outcomes and reduce the chance for iatrogenic damage to the airway. The course will focus attention on quality of life issues in both pediatric and adult patients and review the patient perspective and their needs and identify available support services .

Learning Objectives:

Compare and understand adjuvant therapies, promising new treatments and consider an alternative philosophical approach to RRP management moving to a more medical model.
Provide practical management strategies and "pearls" to increase intersurgical interval, reduce the chance for iatrogenic damage to the airway, maintain the airway and enhance voice outcomes.
Focus attention on the quality of life issues in both pediatric and adult patients and identify support services and management alternatives for those patients with more extensive disease.